Skip to content
Adrienne Monson – Lifestyle
Author:
Tevogen Bio Inc
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
July 13, 2026
Tevogen Announces Formation of a Healthcare Services Initiative
June 9, 2026
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
May 28, 2026
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
May 21, 2026
Letter to Shareholders from CEO Dr. Ryan Saadi
May 18, 2026
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
May 12, 2026
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
April 27, 2026
Tevogen Names Leadership Team to Execute Diversified Growth Strategy
March 9, 2026